设为首页 加入收藏

TOP

Victoza (liraglutide,利拉鲁肽注射剂) (二十)
2013-06-14 10:28:15 来源: 作者: 【 】 浏览:17647次 评论:0
aIntent-to-treat population using last observation on study
bLeast squares mean adjusted for baseline value
**p-value <0.0001
16HOW SUPPLIED/STORAGE HANDLING16.1 How SuppliedVictoza is available in the following package sizes containing disposable, pre-filled, multi-dose pens. Each individual pen delivers doses of 0.6 mg, 1.2 mg, or 1.8 mg (6 mg/mL, 3 mL).
2 x Victoza pen    NDC 0169-4060-12
3 x Victoza pen    NDC 0169-4060-13
Each Victoza pen is for use by a single patient. A Victoza pen should never be shared between patients, even if the needle is changed.
16.2 Recommended StoragePrior to first use, Victoza should be stored in a refrigerator between 36°F to 46°F (2°C to 8°C) (Table 9). Do not store in the freezer or directly adjacent to the refrigerator cooling element. Do not freeze Victoza and do not use Victoza if it has been frozen.
After initial use of the Victoza pen, the pen can be stored for 30 days at controlled room temperature (59°F to 86°F; 15°C to 30°C) or in a refrigerator (36°F to 46°F; 2°C to 8°C). Keep the pen cap on when not in use. Victoza should be protected from excessive heat and sunlight. Always remove and safely discard the needle after each injection and store the Victoza pen without an injection needle attached. This will reduce the potential for contamination, infection, and leakage while also ensuring dosing accuracy.
Table 9 Recommended Storage Conditions for the Victoza Pen
175
HbA1c (%) (Mean)      
Baseline 8.6 8.5 8.4
Change from baseline (adjusted mean) b -1.5 -1.5 -0.5
Difference from placebo + metformin + rosiglitazone arm (adjusted mean) b -0.9** -0.9**  
95% Confidence Interval (-1.1, -0.8) (-1.1, -0.8)  
Patients (%) achieving A1c <7% 54 57 28
Fasting Plasma Glucose (mg/dL) (Mean)      
Baseline 185 181 179
Change from baseline (adjusted mean) b -44 -40 -8
Difference from placebo + metformin + rosiglitazone arm (adjusted mean) b -36** -32**  
95% Confidence Interval (-44,- 27) (-41, -23)  
Body Weight (kg) (Mean)      
Baseline 94.9 95.3 98.5
Change from baseline (adjusted mean) b -2.0 -1.0 +0.6
Difference from placebo + metformin + rosiglitazone arm (adjusted mean) b -2.6** -1.6**  
95% Confidence Interval (-3.4, -1.8) (-2.4, -1.0)
Prior to first use After first use
Refridgerated
36°F to
Tags: 责任编辑:admin
首页 上一页 17 18 19 20 21 下一页 尾页 20/21/21
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇糖尿病治疗药研发动态 下一篇Tecfidera获批用于复发型多发性硬..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位